Bridgewater Associates’s Medtronic MDT Stock Holding History

Bridgewater Associates’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.7M	Buy	482,525 +227,285	+89%	+$18.3M	0.15%	108
2026 Q1	$22.1M	Sell	255,240 -27,146	-10%	-$2.6M	0.1%	144
2025 Q4	$27.1M	Sell	282,386 -55,815	-17%	-$5.42M	0.1%	155
2025 Q3	$32.2M	Buy	338,201 +136,035	+67%	+$12.5M	0.13%	132
2025 Q2	$17.6M	Buy	202,166 +32,570	+19%	+$2.76M	0.07%	191
2025 Q1	$15.2M	Sell	169,596 -341,753	-67%	-$30.6M	0.07%	211
2024 Q4	$40.8M	Sell	511,349 -71,379	-12%	-$6.18M	0.19%	102
2024 Q3	$52.5M	Sell	582,728 -796,240	-58%	-$67M	0.3%	62
2024 Q2	$109M	Buy	1,378,968 +698,741	+103%	+$57.3M	0.57%	30
2024 Q1	$59.3M	Buy	+680,227	New	+$58.1M	0.3%	66
2022 Q3	–	Sell	-2,505,256	Closed	-$225M	–	963
2022 Q2	$225M	Buy	2,505,256 +625,168	+33%	+$63.3M	0.95%	16
2022 Q1	$209M	Buy	+1,880,088	New	+$199M	0.84%	18
2018 Q1	–	Sell	-25,152	Closed	-$2.03M	–	484
2017 Q4	$2.03M	Buy	+25,152	New	+$2.01M	0.02%	158
2017 Q1	–	Sell	-62,300	Closed	-$4.44M	–	288
2016 Q4	$4.44M	Buy	62,300 +31,300	+101%	+$2.46M	0.04%	144
2016 Q3	$2.68M	Buy	+31,000	New	+$2.7M	0.03%	175
2016 Q1	–	Sell	-53,186	Closed	-$4.09M	–	293
2015 Q4	$4.09M	Sell	53,186 -4,000	-7%	-$301K	0.05%	135
2015 Q3	$3.83M	Sell	57,186 -27,946	-33%	-$2.06M	0.05%	156
2015 Q2	$6.31M	Sell	85,132 -87,700	-51%	-$6.7M	0.06%	84
2015 Q1	$13.5M	Buy	172,832 +136,200	+372%	+$10.3M	0.11%	37
2014 Q4	$2.65M	Buy	36,632 +9,587	+35%	+$666K	0.02%	176
2014 Q3	$1.68M	Buy	+27,045	New	+$1.72M	0.01%	184
2014 Q2	–	Sell	-87,345	Closed	-$5.38M	–	348
2014 Q1	$5.38M	Sell	87,345 -45,000	-34%	-$2.62M	0.04%	92
2013 Q4	$7.59M	Buy	132,345 +86,800	+191%	+$4.92M	0.06%	66
2013 Q3	$2.42M	Buy	45,545 +16,500	+57%	+$888K	0.02%	153
2013 Q2	$1.5M	Buy	+29,045	New	+$1.44M	0.01%	171

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bridgewater Associates's MDT Position: Q2 2026 in Review

Bridgewater Associates increased its Medtronic (MDT) stake by 89% in Q2 2026, buying an estimated $18.3M and bringing the position to 482,525 shares worth $37.7M. The position accounts for 0.15% of the portfolio, ranked #108.

Bridgewater Associates first reported a position in MDT in Q2 2013 and has held it in 25 quarters since. The position peaked at $225M in Q2 2022. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Bridgewater Associates held 482,525 shares of Medtronic worth $37.7M as of Q2 2026.
Bridgewater Associates bought 227,285 Medtronic shares in Q2 2026, an estimated $18.3M.
Medtronic made up 0.15% of Bridgewater Associates's portfolio in Q2 2026, its #108 holding.
Bridgewater Associates first reported a position in Medtronic in Q2 2013 and has held it in 25 quarters since.
Bridgewater Associates's Medtronic position peaked at $225M in Q2 2022.
2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.